Health Care: Drugs

Immunoclin Corp (IMCL: OTC)

$5.5 n/a | n/a%
04/30/15 - 12:40 PM ET
Company Profile
Price and Volume
Recent Price 5.50
52 Week High 5.60
52 Week Low 1.45
Avg. Daily Vol. (Mil) 0.00
Beta (3 year) 1.29
Share Related Items
Mkt Cap (Mil) 158.57
Shares Out (Mil) 28.83
Float (Mil) 0.50
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 0.10
Current Ratio 0.10
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 0.00
Price/Book 8.79
Price/Cash Flow -182.00
Per Share Data
Earnings -0.07
Sales 0.00
Book Value 0.63
Cash Flow -0.03
Business Summary
Immunoclin Corp is engaged in immunology research and development skill to serve the pharmaceutical, biotechnology and food industries, providing comprehensive, clinical and basic science research expertise at a commercial scale and quality.
General Information
9107 Wilshire Boulevard
Suite 450
Beverly Hills, CA 90210
Industry : Drugs
Sector: Health Care
Employees: 4
CEO: Dr. Dorothy Bray
Short Interest
Current Month (Mil) 0.00
Previous Month (Mil) 0.00
Short Interest Ratio (Days) 0.00
Management Effectiveness
Return on Equity n.a.
Return on Assets -9.40
Return on Investments -10.30
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with IMCL

Latest IMCL Headlines from TheStreet

More Financial News for IMCL

Press Releases for IMCL

See All Press Releases

Partner Headlines for IMCL

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter